80012-44-8 (盐酸依匹斯汀,EPINASTINE HYDROCHLORIDE)

盐酸依匹斯汀;依匹斯汀盐酸盐;3-氨基-9,13-二氢-1H-二苯并[c,f]-咪唑并[1,5-a]氮杂卓盐酸盐;盐酸依匹司汀;盐酸依匹斯汀 EP标准品;盐酸依匹斯汀系统适应性 EP标准品;

EPINASTINE HYDROCHLORIDE;WAL-801CL;EPINASTINE HCL;EPINASTIN HCL;3-AMINO-9,13B-DIHYDRO-1H-DIBENZ[C,F]IMIDAZO[1,5-A]AZEPINE HYDROCHLORIDE;(+/-)-3-Amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrochloride;9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride;l-3-amino-9,13b-dihydro-1H-dibenzo<c,f>imidazo<1,5-a>azepine hydrochloride;9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride;GFM415S5XL;Q27122286;MFCD00933434;CAS-108929-04-0;SCHEMBL122749;SW220223-1;EPINASTINE HYDROCHLORIDE [MI];Epinastine hydrochloride, European Pharmacopoeia (EP) Reference Standard;EN300-7365601;108929-04-0;DTXSID1046502;epinastin hydrochloride;WAL-801CL HCl;s4253;DTXCID9026502;Epinastine hydrochloride [JAN];DE-114;LP00501;2,4-Diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydron;chloride;Flurinol;HMS3885B15;1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-,hydrochloride;Elestat (TN);CS-0013220;Tox21_112263_1;E0799;80012-44-8;EPINASTINE HYDROCHLORIDE [MART.];Epinastine hydrochloride, United States Pharmacopeia (USP) Reference Standard;EPINASTINE HYDROCHLORIDE [EP MONOGRAPH];AKOS015967222;BCP12119;3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride;HY-B0640A;UNII-GFM415S5XL;3-AMINO-9,13B-DIHYDRO-1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPINE HYDROCHLORIDE, DL-;EPINASTINE HYDROCHLORIDE [USP-RS];WAL 801 CL;Z2756516876;3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine monohydrochloride;EPINASTINE HYDROCHLORIDE (MART.);WAL-802-CL;2,4-diazatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine hydrochloride;VKXSGUIOOQPGAF-UHFFFAOYSA-N;9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine hydrochloride;Elestat;Epinastine monohydrochloride;Epinastine hydrochloride for system suitability, European Pharmacopoeia (EP) Reference Standard;FT-0700527;NCGC00261186-01;NCGC00165791-04;Epinastine hydrochloride (JAN);Epinastine for system suitability;F17420;J-002209;AC-1491;1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPIN-3-AMINE, 9,13B-DIHYDRO-, HYDROCHLORIDE (1:1);KS-1159;FT-0631049;9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride;Tox21_112263;Relestat;Tox21_500501;CHEBI:51037;A857231;Epinastine hydrochloride, >=98% (HPLC), solid;Alesion;CHEMBL1200491;IH-Dibenz(c,f)imidazo(1,5-a)azepin-3-amine, 9,13b-dihydro-, monohydrochloride;EPINASTINE HYDROCHLORIDE (EP MONOGRAPH);EPINASTINE HYDROCHLORIDE [WHO-DD];WAL801;Alesion (TN);EPINASTINE HYDROCHLORIDE (USP-RS);(13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride; 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-, monohydrochloride (9CI); Alesion; Elestat; Epinastine hydrochloride; WAL 801CL;D01713;2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydrochloride;CCG-221805;NCGC00165791-02;HMS3652N21;Epinastine (hydrochloride);Epinastinehydrochloride;EPINASTINE HYDROCHLORIDE [ORANGE BOOK];EX-A1004;3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine hydrochloride;Epinastine HCl;2,4-diazatetracyclo[12.4.0.0(2),?.0?,(1)(2)]octadeca-1(14),7(12),8,10,15,17-hexaen-3-imine hydrochloride;DB-040850;1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine,9,13b-dihydro-, hydrochloride (1:1);2,4-diazatetracyclo[12.4.0.0(2),?.0?,(1)(2)]octadeca-1(18),7(12),8,10,14,16-hexaen-3-imine hydrochloride;9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride;108929-04-0;

MFCD00933434

VKXSGUIOOQPGAF-UHFFFAOYSA-N

1S/C16H15N3.ClH/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16;/h1-8,15H,9-10H2,(H2,17,18);1H

Cl.N12C(N)=NCC1C1C=CC=CC=1CC1C=CC=CC2=1